Skip to main content
. 2017 May 23;8(46):81273–81284. doi: 10.18632/oncotarget.18111

Table 2. Summary of neuropsychologic assessments.

Tests Patients Treated With Chemotherapy
(CT)(n =19)
Healthy Controls
(HC)(n=11)
Group Time Interaction With Repeated Measures ANOVA
t1 t2 Paired t-test t1 t2 Paired t-test F P
mean SD mean SD mean SD mean SD
AVLT 31.42 8.051 26.53 8.650 0.016* 29.64 11.138 30.00 11.533 0.542 4.554 0.042*
short term 10.53 1.982 10.00 2.582 0.340 11.55 2.659 12.00 2.966 0.138 1.746 0.197
long term 8.74 3.070 8.11 3.430 0.383 8.82 3.710 9.00 3.899 0.506 0.725 0.402
recognition 12.16 3.516 8.42 3.761 0.001* 9.27 5.287 9.00 5.177 0.341 8.076 0.008*
Digit Symbol 52.84 15.770 51.26 15.202 0.450 54.64 14.080 55.55 14.123 0.264 0.809 0.376
Digit Span
forward
6.05 1.353 5.89 1.629 0.546 6.36 1.286 6.73 1.191 0.167 1.825 0.188
backward 5.05 1.026 5.11 1.761 0.848 5.91 1.514 5.73 1.272 0.341 0.375 0.545
MOCA 25.95 3.659 25.58 3.878 0.414 26.91 2.982 27.00 2.793 0.724 0.561 0.460
FACT-COG 106.21 23.220 89.00 25.126 0.003* 117.18 7.808 119.64 7.103 0.036* 8.896 0.006*
CogPCI 57.16 13.937 46.11 15.613 0.001* 63.82 6.369 64.91 5.431 0.210 10.094 0.004*
CogQOL 12.21 4.650 12.05 4.288 0.888 14.55 2.544 15.73 0.647 0.168 0.717 0.404
CogOth 14.26 3.177 12.21 4.276 0.070 15.09 1.868 15.45 1.293 0.341 2.823 0.104
CogPCA 22.58 4.598 18.63 6.335 0.019* 23.73 3.977 23.55 3.698 0.640 3.354 0.078

* Statistically significant; ANOVA: analysis of variance; AVLT: Auditory Verbal Learning Test; MOCA: Montreal Cognitive Assessment; FACT-COG: Functional Assessment of Cancer Therapy-Cognitive Function; CogPCI: perceived cognitive impairments; CogQOL: impact of perceived impairments on quality of life; CogOth: comments from others; CogPCA: perceived cognitive abilities; SD: standard deviation.